Xvivo Perfusion AB (XVIPF)
30.95
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Xvivo Perfusion Net Income (Quarterly) : 1.739M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.739M |
| March 31, 2026 | 3.971M |
| December 31, 2025 | 3.364M |
| September 30, 2025 | 0.456M |
| June 30, 2025 | 0.1628M |
| March 31, 2025 | -1.162M |
| December 31, 2024 | 3.375M |
| September 30, 2024 | 8.234M |
| June 30, 2024 | 2.544M |
| March 31, 2024 | 2.192M |
| December 31, 2023 | 6.419M |
| September 30, 2023 | 0.2112M |
| June 30, 2023 | 0.6532M |
| March 31, 2023 | 1.358M |
| December 31, 2022 | 0.0684M |
| September 30, 2022 | 0.5116M |
| June 30, 2022 | 0.7645M |
| March 31, 2022 | 0.5101M |
| December 31, 2021 | 1.375M |
| September 30, 2021 | -0.1306M |
| June 30, 2021 | -1.063M |
| March 31, 2021 | 0.718M |
| December 31, 2020 | -2.273M |
| September 30, 2020 | -1.656M |
| June 30, 2020 | -1.655M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.6758M |
| December 31, 2019 | -0.1978M |
| September 30, 2019 | 0.514M |
| June 30, 2019 | 0.2357M |
| March 31, 2019 | -0.0343M |
| December 31, 2018 | 0.5401M |
| September 30, 2018 | 0.0111M |
| June 30, 2018 | 0.4486M |
| March 31, 2018 | 0.4692M |
| December 31, 2017 | 0.669M |
| September 30, 2017 | -0.0431M |
| June 30, 2017 | 0.1239M |
| March 31, 2017 | -0.005M |
| December 31, 2016 | -0.0641M |
| September 30, 2016 | -0.0649M |
| June 30, 2016 | 0.185M |
| March 31, 2016 | 0.1317M |
| December 31, 2015 | 0.3292M |
| September 30, 2015 | 0.1326M |
| June 30, 2015 | 0.1524M |
| March 31, 2015 | -0.1225M |
| December 31, 2014 | -0.042M |
| September 30, 2014 | 0.2126M |
| June 30, 2014 | 0.1139M |
| March 31, 2014 | 0.2817M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Getinge AB | 89.59M |
| Paxman AB | 0.2737M |
| Enovis Corp. | -1.036M |
| Edwards Lifesciences Corp. | 241.40M |
| Intuitive Surgical, Inc. | 823.20M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 25.52M |
| Total Expenses (Quarterly) | 23.78M |
| EPS Diluted (Quarterly) | 0.0552 |
| Enterprise Value | 955.97M |
| Gross Profit Margin (Quarterly) | 63.23% |
| Profit Margin (Quarterly) | 6.81% |
| Earnings Yield | 0.98% |
| Operating Earnings Yield | 1.19% |
| Normalized Earnings Yield | 0.9738 |